Shopping Cart
- Remove All
- Your shopping cart is currently empty
Antitumor Agent-92, an Icaritin derivative, induces G0/G1 phase cell cycle arrest and promotes apoptosis. This compound shows promise for hepatocellular carcinoma (HCC) research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | Antitumor Agent-92, an Icaritin derivative, induces G0/G1 phase cell cycle arrest and promotes apoptosis. This compound shows promise for hepatocellular carcinoma (HCC) research [1]. |
In vitro | Antitumor agent-92 (Compound 11c; 2-8 μM; 48 hours) induces apoptosis in HepG2 and SMMC-7721 cells, with increased effects at higher concentrations [1]. The compound also promotes G0/G1 phase arrest in these cells [1]. Additionally, Antitumor agent-92 upregulates P21 and downregulates Cdc2 p34 and CDK4 [1]. |
Molecular Weight | 611.68 |
Formula | C33H41NO10 |
Cas No. | 2922842-01-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.